Diphtheria tetanus toxoid and pertussis third-dose (DTP3) in Indonesia
Indonesia: Diphtheria tetanus toxoid and pertussis third-dose (DTP3) was 82.0% in 2025. ▲ Rising
Diphtheria tetanus toxoid and pertussis third-dose (DTP3) in Indonesia, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, diphtheria tetanus toxoid and pertussis third-dose (dtp3) in Indonesia stood at 82.0%.
Compared with earlier readings it is up 5.1% on the previous year and down 2.4% over ten years.
Over the whole period, diphtheria tetanus toxoid and pertussis third-dose (dtp3) in Indonesia peaked at 92.0% in 2013 and was at its lowest, 67.0%, in 2021.
That places Indonesia 146th out of 194 countries with data for 2025, putting it in the bottom quarter.
The long-run direction has been consistently rising across the 26 years of available data.
Diphtheria tetanus toxoid and pertussis third-dose (DTP3) in Indonesia, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 75.0% | — |
| 2001 | 76.0% | +1.3% |
| 2002 | 70.0% | -7.9% |
| 2003 | 71.0% | +1.4% |
| 2004 | 71.0% | +0.0% |
| 2005 | 72.0% | +1.4% |
| 2006 | 72.0% | +0.0% |
| 2007 | 73.0% | +1.4% |
| 2008 | 77.0% | +5.5% |
| 2009 | 78.0% | +1.3% |
| 2010 | 81.0% | +3.8% |
| 2011 | 81.0% | +0.0% |
| 2012 | 87.0% | +7.4% |
| 2013 | 92.0% | +5.7% |
| 2014 | 88.0% | -4.3% |
| 2015 | 84.0% | -4.5% |
| 2016 | 84.0% | +0.0% |
| 2017 | 85.0% | +1.2% |
| 2018 | 85.0% | +0.0% |
| 2019 | 85.0% | +0.0% |
| 2020 | 77.0% | -9.4% |
| 2021 | 67.0% | -13.0% |
| 2022 | 91.0% | +35.8% |
| 2023 | 83.0% | -8.8% |
| 2024 | 78.0% | -6.0% |
| 2025 | 82.0% | +5.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 73.5% | 70.0% | 78.0% | 10 |
| 2010s | 85.2% | 81.0% | 92.0% | 10 |
| 2020s | 79.7% | 67.0% | 91.0% | 6 |
Countries ranked near Indonesia
- 146 Gambia 82.0% compare
- 146 Republic of Moldova 82.0% compare
- 146 Kyrgyzstan 82.0% compare
- 146 Namibia 82.0% compare
More health data for Indonesia
- Un projection of annual infant deaths, annual growth rate -1.35 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.4924 % change on previous year (2090)
- Heat deaths vs projected death rates 1,286 (2090)
- Un projection of annual infant deaths 16,463 (2100)
- Population ages 0-14, female, annual growth rate -0.662 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, female, per capita 0.118 units per person (2025)
- Population ages 0-14, male, annual growth rate -0.636 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, male, per capita 0.1245 units per person (2025)
Frequently asked questions
- What is diphtheria tetanus toxoid and pertussis third-dose (dtp3) in Indonesia?
- Diphtheria tetanus toxoid and pertussis third-dose (dtp3) in Indonesia was 82.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest diphtheria tetanus toxoid and pertussis third-dose (dtp3) recorded in Indonesia?
- The highest recorded value was 92.0% in 2013.
- What is the lowest diphtheria tetanus toxoid and pertussis third-dose (dtp3) recorded in Indonesia?
- The lowest recorded value was 67.0% in 2021.
- How does Indonesia rank for diphtheria tetanus toxoid and pertussis third-dose (dtp3)?
- Indonesia ranks 146th out of 194 countries with data for 2025.
- Is diphtheria tetanus toxoid and pertussis third-dose (dtp3) rising or falling in Indonesia?
- Over the last ten years it is down 2.4%. The long-run trend across the full record is rising.
- Where does this Indonesia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Diphtheria tetanus toxoid and pertussis third-dose (DTP3) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).